PX1 Research provides synthetic Gonadorelin engineered specifically for in vitro assays and animal model investigation. Each lot undergoes rigorous third-party testing—including RP-HPLC purity verification, mass spectrometry, and endotoxin screening—to ensure uncompromising analytical reproducibility for institutional researchers.
PX1 Research provides synthetic Gonadorelin engineered specifically for in vitro assays and animal model investigation. Each lot undergoes rigorous third-party testing—including RP-HPLC purity verification, mass spectrometry, and endotoxin screening—to ensure uncompromising analytical reproducibility for institutional researchers.
Gonadorelin for sale as a research-grade peptide refers to the synthetic decapeptide identical to endogenous gonadotropin-releasing hormone (GnRH). Designed strictly for in vitro assays and preclinical laboratory research, high-purity gonadorelin allows investigators to study hypothalamic-pituitary-gonadal (HPG) axis receptor signaling, gonadotropin synthesis, and pulsatile luteinizing hormone (LH) release.
When purchasing gonadorelin for experimental workflows, institutional investigators require absolute analytical certainty. Impurities, trifluoroacetic acid (TFA) residual spikes, or endotoxin contamination can confound receptor-binding kinetics and skew cellular signaling data. PX1 Research manufactures and distributes laboratory-grade reagents produced in domestic, GMP-compliant facilities to ensure consistent lot-to-lot performance across our entire research peptide catalog.
Gonadorelin is a synthetic decapeptide possessing the primary amino acid sequence Pyroglutamyl-Histidyl-Tryptophyl-Seryl-Tyrosyl-Glycyl-Leucyl-Arginyl-Prolyl-Glycine amide (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2). With a molecular formula of C55H75N17O13 and a precise molecular weight of approximately 1182.3 g/mol, the peptide features an N-terminal pyroglutamate residue and a C-terminal glycinamide modification.
These specific terminal modifications are essential for conformational stability and high-affinity interaction with the GnRH receptor (GnRH-R). In laboratory settings, the structural integrity of this decapeptide determines its binding kinetics to G-protein coupled receptors (GPCRs) expressed on anterior pituitary gonadotroph cell lines. Detailed molecular modeling studies depend on receiving freeze-dried peptides devoid of truncated sequence fragments or racemized amino acids.
In preclinical model systems, gonadorelin acts as a native agonist at the gonadotropin-releasing hormone receptor (GnRH-R), a seven-transmembrane G-protein-coupled receptor located primarily on the cell membranes of anterior pituitary gonadotrophs. Upon receptor binding, gonadorelin initiates a intracellular cascade via the Gq/11 protein pathway, activating phospholipase C (PLC).
PLC activation generates inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), triggering rapid intracellular calcium ion (Ca2+) mobilization from the endoplasmic reticulum and activating protein kinase C (PKC). In cell culture models, this signaling cascade stimulates the transcription and exocytosis of gonadotropins, specifically luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In vitro data indicate that the duration and frequency of gonadorelin exposure dictate whether receptor response leads to sustained stimulation or receptor desensitization and downregulation.
Within neuroendocrine and endocrine research, investigators frequently compare native gonadorelin to modified GnRH analogues to evaluate half-life differences, binding affinities, and receptor desensitization rates. While native gonadorelin exhibits a rapid clearance profile in animal models, synthetic modifications yield compounds with distinct pharmacological behaviors.
In comparative preclinical assays, native gonadorelin serves as the baseline control for native pulsatile GnRH-R activation. In contrast, potent long-acting agonists such as triptorelin and leuprolide possess D-amino acid substitutions at position 6, which drastically increase enzymatic resistance and receptor residence time, leading to rapid receptor desensitization. Additionally, upstream hypothalamic regulators like kisspeptin-10 act on KISS1R to stimulate endogenous GnRH release, offering a distinct targeted pathway for HPG axis research. Investigators exploring comprehensive neuroendocrine pathways can review additional targets in our expanded research library.
Research-grade gonadorelin is extensively utilized across several scientific disciplines to explore reproductive endocrinology, GPCR desensitization mechanisms, and signal transduction pathways. Typical preclinical experimental paradigms include:
1. Gonadotroph Signal Transduction Assays: Measuring real-time intracellular Ca2+ flux and IP3 accumulation in immortalized pituitary cell lines (e.g., LβT2 or αT3-1 cells) following peptide application.
2. Receptor Downregulation Studies: Evaluating the rate of GnRH-R internalization and desensitization under continuous versus pulsatile peptide perfusion regimes.
3. Animal Model HPG Axis Dynamics: Assessing acute pituitary LH and FSH secretagogue responses in rodent and non-human primate models to map neuroendocrine feed-forward loops.
4. Synthetic Sequence Modification: Utilizing native gonadorelin as a scaffold for peptidomimetic synthesis and structure-activity relationship (SAR) studies.
When procuring compounds labeled as gonadorelin for sale, research validity depends entirely on stringently verified purity. Unpurified or poorly processed peptides often contain synthesis side-products, including deletion sequences, truncated fragments, and unreacted coupling reagents, which distort binding assays and generate false quantitative data.
PX1 Research enforces strict quality assurance protocols for every batch of research peptides. Quality verification standards include:
• Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Ensures purity levels equal to or exceeding 99.0%, confirming a single, uniform chromatographic peak.
• Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular mass (1182.3 Da) and guarantees sequence accuracy without truncations.
• Endotoxin Testing (LAL Assay): Verifies bacterial endotoxin levels remain below 0.01 EU/mg, preventing cell culture toxicity or non-specific inflammatory signaling in vivo.
• Trifluoroacetic Acid (TFA) Removal: Ensures residual salt concentrations do not interfere with cell viability or enzymatic assays.
Every vial shipped from PX1 Research includes a lot-specific Certificate of Analysis (COA) issued by an independent ISO 17025 accredited testing laboratory.
Gonadorelin is supplied as a sterile, lyophilized (freeze-dried) powder to maximize chemical stability during transport and storage. Proper laboratory preparation techniques are required to maintain structural stability and prevent aggregation or cleavage.
To reconstitute lyophilized gonadorelin for analytical workflows, laboratory personnel should adhere to aseptic standard operating procedures:
1. Equilibration: Allow the vial to reach room temperature (20°C to 25°C) prior to reconstitution to minimize moisture condensation within the lyophilized cake.
2. Solvent Selection: Reconstitute using sterile, laboratory-grade Bacteriostatic Water (0.9% benzyl alcohol) for multi-use analytical setups, or sterile phosphate-buffered saline (PBS, pH 7.4) for immediate cell culture application.
3. Reconstitution Technique: Direct the solvent stream down the inner glass wall of the vial rather than directly onto the lyophilized cake. Gently swirl the vial in a circular motion until fully dissolved. Never vortex high-purity peptides, as mechanical shear forces can induce protein denaturation or aggregation.
For additional guidelines regarding solvent compatibility and concentration calculations, consult our technical peptide reconstitution protocols.
Peptides are inherently susceptible to chemical degradation via hydrolysis, oxidation, and deamidation if exposed to sub-optimal environmental conditions. Lyophilized gonadorelin should be stored at -20°C for short-to-medium term storage, or at -80°C for long-term archival storage, shielded from direct light.
Once reconstituted into solution, working aliquots should be maintained at 2°C to 8°C and utilized within short timeframes, or flash-frozen in single-use aliquots at -80°C to prevent repeated freeze-thaw cycles. PX1 Research utilizes domestic, climate-controlled shipping facilities in California and Arizona, providing same-day dispatch for orders placed Monday through Friday to protect compound integrity throughout transit.
Principal investigators, contract research organizations (CROs), and university facilities require dependable supply chains capable of delivering high-volume, uniform lots. Batch-to-batch consistency is crucial when conducting long-term, longitudinal studies that require standard baseline measurements across multiple experimental cohorts.
PX1 Research accommodates institutional procurement requirements by offering bulk packaging, dedicated lot reservation, and custom analytical reporting. Academic and commercial institutions seeking bulk quantities or recurring delivery schedules can set up a dedicated wholesale lab account to access streamlined procurement and enterprise-tier support.
What is the primary research application of Gonadorelin?
In preclinical research, Gonadorelin is used to study gonadotropin-releasing hormone receptor (GnRH-R) activation, pituitary signal transduction pathways, and the dynamics of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release in cell cultures and animal models.
How does PX1 Research verify the purity of Gonadorelin?
Every lot of Gonadorelin undergoes analytical testing at an independent ISO 17025 accredited laboratory. Purity is validated via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to ensure ≥99% purity, and identity is confirmed through Electrospray Ionization Mass Spectrometry (ESI-MS). Each shipment includes a lot-specific Certificate of Analysis (COA).
What are the endotoxin limits for PX1 Research peptides?
PX1 Research enforces strict endotoxin screening using Limulus Amebocyte Lysate (LAL) testing, ensuring endotoxin levels are verified below 0.01 EU/mg to prevent confounding immune responses in preclinical assays.
How should lyophilized Gonadorelin be stored upon arrival?
Lyophilized Gonadorelin should be stored in a freezer at -20°C or -80°C away from light. Stored under these dry, sub-zero conditions, the freeze-dried peptide maintains chemical stability for extended periods.
What solvent should be used to reconstitute Gonadorelin for in vitro assays?
For cell culture and in vitro signaling assays, sterile phosphate-buffered saline (PBS, pH 7.4) or sterile laboratory-grade water is recommended. For multi-entry laboratory procedures, sterile bacteriostatic water containing 0.9% benzyl alcohol may be utilized.
How does Gonadorelin differ from long-acting GnRH agonists like Triptorelin?
Gonadorelin possesses the exact native amino acid sequence of GnRH, resulting in a short biological half-life ideal for studying native pulsatile kinetics. Agonists like Triptorelin feature D-amino acid modifications that resist enzymatic degradation, causing prolonged receptor occupancy and sustained downregulation.
Where is PX1 Research Gonadorelin manufactured and shipped from?
PX1 Research compounds are manufactured in domestic, USA-based GMP-compliant facilities. Orders are fulfilled and dispatched directly from our centralized distribution centers in California and Arizona.
Can Gonadorelin be purchased for human clinical or therapeutic use?
No. Gonadorelin supplied by PX1 Research is strictly designated for laboratory research use only (RUO). It is not for human or veterinary consumption, administration, clinical therapy, or diagnostic procedures.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.